Latest Pharmacy News
J&J COVID-19 Vaccine 66 Percent Effective in Interim Analysis
posted January 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
J&J, Novavax COVID Vaccines Work Well, But Weaken Against a New Variant
EU Regulator Approves Oxford-AstraZeneca COVID-19 Vaccine
posted January 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Full-Dose Heparin May Aid Moderately Ill COVID-19 Patients
New COVID-19 Variants May Weaken Efficacy of Vaccines
posted January 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
COVID-19 Antibodies Decline Quickly in Donated Plasma: Study
Early Anticoagulation May Not Up Survival in Severe COVID-19
posted January 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
HealthDay Reports: Why Is Coronavirus a Bigger Worry for People With Diabetes?
Editor's Recommendations
NOACs Linked to Slower Cognitive Decline in Patients With A-Fib, Alzheimer Disease 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
New Guideline Details Diagnosis, Treatment of Acute Pulmonary Embolism .jpg)
Guideline Updated for Early Management of Acute Ischemic Stroke Related Articles
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Financial Incentives Boost Tobacco Abstinence in Underserved Adults 
Withdrawal From Medetomidine Increasingly Seen in ICUs Pharmacy Conference Highlights
Pharmacy Monthly Briefings
Pharmacy Conference News
Stay Connected
